Purchase Order HHSN269201700607P

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC valued at $17,029.90 on August 24, 2018, with ultimate completion on August 24, 2019. The order is a firm fixed-price acquisition with no set-aside designation. Performance occurs in Valencia, California. The source does not specify the products or services procured under this order.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $85,445.00 on August 24, 2018. Place of performance is Valencia, California. The order carries firm fixed price terms and an ultimate completion date of September 23, 2018. No set-aside applied. The originating pre-solicitation was posted August 6, 2018 with a due date of August 16, 2018.</p>

<p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $7,735.00 on August 28, 2017, with final completion on September 28, 2017. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $17,680.81 on June 15, 2018, with an ultimate completion date of June 29, 2018. The order is firm fixed price with no set-aside designation. Place of performance is Bethesda, Maryland. The source does not disclose the specific items or services procured under this purchase order.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $12,770.00 on June 5, 2018, with an ultimate completion date of June 15, 2018. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Qiagen, LLC for $8,165.40 on November 22, 2017, with a completion date of December 1, 2017. Performance will occur in Bethesda, Maryland. The order is firm fixed price and carries no set-aside designation. The specific products or services procured are not detailed in the source material.</p>

<p>The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $11,193.00 on August 6, 2018, for firm fixed price delivery to Valencia, California. The order completed on August 6, 2018. No set-aside was applied.</p>

The NIH Clinical Center awarded a purchase order to Qiagen, LLC on June 13, 2018, with a ceiling value of $216,766.82 for firm fixed-price delivery of QIAGEN products and services. The order's ultimate completion date was December 31, 2020. Place of performance is Valencia, California. This purchase order is now being administratively de-obligated to close unexpended fiscal year 2021 funding in preparation for the September 30, 2026 period-of-availability closing, in accordance with 31 U.S.C....

The NIH Clinical Center awarded a purchase order to Qiagen, LLC valued at $15,090 on July 28, 2017, with ultimate completion by August 27, 2018. Performance occurs in Bethesda, Maryland. The order is firm fixed price with no set-aside designation. The purchase covers molecular diagnostics products and consumables, consistent with Qiagen's core offerings in DNA/RNA extraction kits, reagents, and related laboratory supplies supporting the Clinical Center's biomedical research and diagnostic...